Previous studies have reported that a right colon PTL is associated with a lack of benefit when treated with EGFR-inhibitors; additionally, when the tumor is RAS wt [2,3,10] or RAS & BRAF wt and pMMR [49]. The gene discussed is EGFR; the disease is neoplasm.